期刊
TRENDS IN CARDIOVASCULAR MEDICINE
卷 27, 期 4, 页码 239-246出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2016.11.002
关键词
L5; Cardiovascular disease; Electronegative low-density lipoprotein
资金
- TUBITAK Scientist Support Directorate-International Postdoctoral Research Fellowship Program [BIDEB-2219, 1059B191401803, 1059B191401533]
- Kaohsiung Medical University [KMU-TP104D00]
- Kaohsiung Medical University Hospital [KMUH103-10V03]
- Vascular and Medicinal Research Fund, Texas Heart Institute [765-64050]
Cardiovascular disease (CVD) is a health problem of great concern to both the public and medical authorities. Low-density lipoprotein (LDL) has been reported to play an important role in both the development and progression of CVD, but studies are underway to determine how LDL exerts its effects. In recent years, it has been found that LDL has several subfractions, each of which affects endothelial function differently; L5, the most electronegative fraction, has been shown to be unique in that it induces an atherogenic response. This review examines the current knowledge concerning the relationships between L5 and CVD and highlights the role of L5 in the pathophysiology of CVD, especially with regards to atherosclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据